Cite
MLA Citation
K. Dunleavy et al.. “RISK‐ADAPTED THERAPY IN ADULTS WITH BURKITT LYMPHOMA: UPDATED RESULTS OF a MULTICENTER PROSPECTIVE PHASE II STUDY OF DA‐EPOCH‐R.” Hematological oncology, vol. 35, n.d., pp. 133–134. http://access.bl.uk/ark:/81055/vdc_100047470319.0x000025